In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTL...
Saved in:
Published in | Retrovirology Vol. 6; no. 1; p. 19 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
19.02.2009
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases.
We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP.
These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis. |
---|---|
AbstractList | BACKGROUND: Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. RESULTS: We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. CONCLUSION: These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis. Abstract Background Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. Results We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. Conclusion These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis. Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases.BACKGROUNDRecently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases.We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP.RESULTSWe quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP.These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.CONCLUSIONThese findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis. Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis. |
ArticleNumber | 19 |
Audience | Academic |
Author | Matsuoka, Masao Saito, Kousuke Matsuzaki, Toshio Ohara, Yoshiro Satou, Yorifumi Arimura, Kimiyoshi Saito, Mineki Yasunaga, Jun-ichirou |
AuthorAffiliation | 4 Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan 2 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan 1 Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0293, Japan 3 Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan |
AuthorAffiliation_xml | – name: 4 Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan – name: 3 Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan – name: 2 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan – name: 1 Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0293, Japan |
Author_xml | – sequence: 1 givenname: Mineki surname: Saito fullname: Saito, Mineki – sequence: 2 givenname: Toshio surname: Matsuzaki fullname: Matsuzaki, Toshio – sequence: 3 givenname: Yorifumi surname: Satou fullname: Satou, Yorifumi – sequence: 4 givenname: Jun-ichirou surname: Yasunaga fullname: Yasunaga, Jun-ichirou – sequence: 5 givenname: Kousuke surname: Saito fullname: Saito, Kousuke – sequence: 6 givenname: Kimiyoshi surname: Arimura fullname: Arimura, Kimiyoshi – sequence: 7 givenname: Masao surname: Matsuoka fullname: Matsuoka, Masao – sequence: 8 givenname: Yoshiro surname: Ohara fullname: Ohara, Yoshiro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19228429$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kl2L1DAUhousuB9666UEBFGws0natM2NMC7qDKwoOHrhTUiT05msbVOTzOj8N3-cqbM77OhKCGnPec_DOcl7mhz1tockeUzwhJCqOCdlTtO84DgtUsLvJSf7wNGt7-Pk1PsrjDNS4epBckw4pVVO-Unya96jjdlYBD8HB94b2yPboLACNHv9FS2hh_F_trj8khKkrHPQygAe_TBhhQZnN8bJFrVW6pfI9E0ru04G67aok-4bOI9kr5E2HqQH5GEDzoRtVN4gpfdWmYjUqNtCawcZVtvz4OxgVAT7QfpgFBqkk3GDNx49n03fny8-fXzxMLnfyNbDo-vzLPn89s3iYpZefng3v5hepjUreUihorouOeXAFCmI1JTSWuckp6TMqprFfKNyignlZV0QqBiVtNAyzwnJVMays2S-42orr8TgTJxtK6w04k_AuqWQLnbZgmhUrXGjMNOc5aUGyRUpma4rxkrJMh5Zr3asYV13oBX0IV7gAfQw05uVWNqNoAXL8gJHwHQHqI39D-Awo2wnRieI0QmiEGRs4tl1E85-X4MPojNeQdvKHuzai6LEuOJx-rPk6U64lHG4-L42ItUoFlPCGckx5yNucocqLg2dUdGwjYnxg4Inty9h3_yNL6Mg3wmUs947aIQyQYbozkg2rSBYjPb_d67JX2V78t0FvwEQ3weN |
CitedBy_id | crossref_primary_10_1158_0008_5472_CAN_15_0942 crossref_primary_10_3389_fmicb_2018_00558 crossref_primary_10_1111_trf_12911 crossref_primary_10_1016_j_leukres_2024_107454 crossref_primary_10_1155_2012_391953 crossref_primary_10_1186_1742_4690_8_102 crossref_primary_10_12688_wellcomeopenres_12469_2 crossref_primary_10_3389_fmicb_2019_00885 crossref_primary_10_12688_wellcomeopenres_12469_1 crossref_primary_10_1007_s11033_023_08626_8 crossref_primary_10_3389_fmicb_2020_614940 crossref_primary_10_3389_fmicb_2022_897346 crossref_primary_10_3389_fmed_2022_867478 crossref_primary_10_1371_journal_ppat_1001117 crossref_primary_10_3390_v7072793 crossref_primary_10_1186_1742_4690_9_46 crossref_primary_10_1186_1742_2094_11_18 crossref_primary_10_3389_fmicb_2018_00285 crossref_primary_10_1128_JVI_00413_19 crossref_primary_10_2222_jsv_62_113 crossref_primary_10_3390_ijms23105486 crossref_primary_10_2217_fmb_09_13 crossref_primary_10_1093_carcin_bgt221 crossref_primary_10_1159_000371766 crossref_primary_10_1038_onc_2010_537 crossref_primary_10_1111_j_1365_2133_2010_09681_x crossref_primary_10_1007_s13365_020_00881_w crossref_primary_10_1051_medsci_2010264391 crossref_primary_10_1128_JVI_02088_09 crossref_primary_10_1371_journal_ppat_1004575 crossref_primary_10_1586_eri_09_97 crossref_primary_10_1016_j_virol_2016_04_012 crossref_primary_10_1586_1744666X_2014_966690 crossref_primary_10_1371_journal_ppat_1006597 crossref_primary_10_1155_2012_213653 crossref_primary_10_1186_s12977_016_0249_x crossref_primary_10_1590_S0037_86822012000500002 crossref_primary_10_1186_s12985_017_0902_6 crossref_primary_10_1186_s12985_019_1270_1 crossref_primary_10_1371_journal_pntd_0008361 crossref_primary_10_2169_internalmedicine_52_0845 crossref_primary_10_1371_journal_pntd_0001729 crossref_primary_10_1371_journal_ppat_1009219 crossref_primary_10_1080_10408363_2022_2157791 crossref_primary_10_3389_fimmu_2022_991928 crossref_primary_10_1186_1742_4690_6_71 crossref_primary_10_1186_s12977_019_0484_z crossref_primary_10_1186_1742_4690_6_76 crossref_primary_10_1186_1742_4690_6_77 crossref_primary_10_1186_s12977_019_0487_9 crossref_primary_10_1371_journal_ppat_1002025 crossref_primary_10_1371_journal_ppat_1003630 crossref_primary_10_1016_S1473_3099_20_30328_5 crossref_primary_10_3389_fmicb_2017_02615 crossref_primary_10_1371_journal_pntd_0002028 crossref_primary_10_3390_v11110974 crossref_primary_10_1007_s00428_025_04074_w crossref_primary_10_1111_cen3_12395 crossref_primary_10_1158_2326_6066_CIR_15_0148 crossref_primary_10_3390_mi12020159 crossref_primary_10_1186_1743_422X_11_172 crossref_primary_10_1002_jmv_24721 crossref_primary_10_1186_s12977_014_0116_6 crossref_primary_10_3389_fcimb_2020_580371 crossref_primary_10_1155_2012_259045 crossref_primary_10_1186_1742_4690_10_19 crossref_primary_10_1007_s11538_011_9657_1 crossref_primary_10_1186_s12977_018_0454_x crossref_primary_10_1186_s12977_016_0263_z crossref_primary_10_1002_rmv_1745 crossref_primary_10_3389_fimmu_2022_984274 crossref_primary_10_1093_infdis_jir708 crossref_primary_10_3390_v2092037 crossref_primary_10_1007_s00430_019_00625_6 crossref_primary_10_3389_fmicb_2017_02563 crossref_primary_10_3389_fmicb_2017_02684 crossref_primary_10_1128_CMR_00063_09 crossref_primary_10_1128_JVI_00853_17 crossref_primary_10_1016_j_neurol_2011_12_006 crossref_primary_10_1158_0008_5472_CAN_13_3564 crossref_primary_10_1016_j_virusres_2016_11_009 crossref_primary_10_1002_jmv_24342 crossref_primary_10_1016_S0929_6646_10_60112_X crossref_primary_10_1016_j_bjid_2021_101594 crossref_primary_10_3390_jcm6120111 crossref_primary_10_1182_blood_2010_11_321364 crossref_primary_10_1371_journal_ppat_1001274 crossref_primary_10_1038_onc_2012_450 crossref_primary_10_1371_journal_ppat_1002480 crossref_primary_10_1016_j_coviro_2013_08_010 crossref_primary_10_1177_0300985810370009 crossref_primary_10_3389_fmicb_2018_00985 crossref_primary_10_3389_fviro_2021_792659 crossref_primary_10_1002_acn3_51437 crossref_primary_10_1007_s13365_015_0407_2 crossref_primary_10_2177_jsci_39_207 crossref_primary_10_1002_jmv_29912 crossref_primary_10_1128_JVI_00661_12 crossref_primary_10_1186_1742_4690_8_19 crossref_primary_10_1128_JVI_01094_14 crossref_primary_10_1128_spectrum_01518_23 crossref_primary_10_1186_s12977_019_0499_5 crossref_primary_10_1093_infdis_jiq078 crossref_primary_10_1016_j_mam_2010_06_002 crossref_primary_10_1186_s12985_017_0802_9 crossref_primary_10_1371_journal_ppat_1002231 crossref_primary_10_3390_v3060714 crossref_primary_10_1016_j_ijid_2024_107058 crossref_primary_10_3390_v8020034 crossref_primary_10_1007_s13365_020_00832_5 crossref_primary_10_3390_v3050456 crossref_primary_10_1016_j_pharmthera_2020_107669 crossref_primary_10_1186_s12985_023_02264_z crossref_primary_10_1371_journal_pntd_0005285 crossref_primary_10_1158_0008_5472_CAN_16_0361 crossref_primary_10_1016_j_revmed_2014_11_013 crossref_primary_10_1038_s41408_023_00841_7 crossref_primary_10_3389_fmicb_2022_988944 crossref_primary_10_1186_1742_4690_9_98 crossref_primary_10_1186_s12977_014_0074_z crossref_primary_10_1590_S0100_879X2010007500107 crossref_primary_10_1186_s12885_018_5209_5 crossref_primary_10_2222_jsv_69_37 crossref_primary_10_3390_v16101616 crossref_primary_10_1016_j_jcv_2012_10_003 crossref_primary_10_3390_v3091532 crossref_primary_10_1186_1742_4690_10_51 crossref_primary_10_1182_blood_2010_05_284141 crossref_primary_10_3389_fmicb_2020_01062 crossref_primary_10_4161_viru_1_1_9868 |
Cites_doi | 10.1016/S0140-6736(85)92734-5 10.1074/jbc.M307275200 10.1002/ijc.24012 10.1099/vir.0.80509-0 10.1128/JVI.00480-06 10.1016/0167-5699(88)91203-0 10.1097/00005072-199401000-00009 10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B 10.1126/science.2888190 10.1073/pnas.96.7.3848 10.1182/blood-2005-11-4551 10.1073/pnas.0507631103 10.1038/nm1389 10.1073/pnas.77.12.7415 10.1086/315897 10.1111/j.1365-2257.2005.00698.x 10.3109/13550289609146899 10.1111/j.1349-7006.1992.tb00092.x 10.1128/JVI.63.7.3185-3189.1989 10.1146/annurev.immunol.19.1.475 10.1007/s004010050435 10.1038/sj.onc.1208970 10.1126/science.2888191 10.1182/blood.V85.7.1865.bloodjournal8571865 10.1186/1742-4690-5-34 10.4049/jimmunol.165.12.7278 10.1002/mus.880160507 10.1212/WNL.33.11.1444 10.1006/viro.1993.1580 10.1212/WNL.41.3.457 10.1097/00005072-199809000-00005 10.1016/S0140-6736(87)91362-6 10.1182/blood.V99.1.88 10.1038/341072a0 10.1002/(SICI)1096-9896(1998100)186:2<209::AID-PATH162>3.0.CO;2-I 10.1128/JVI.76.24.12813-12822.2002 10.1016/S0140-6736(86)91298-5 10.1186/1742-4690-2-27 10.1182/blood-2005-04-1730 10.3109/13550289809114225 10.1126/science.1887217 10.1212/WNL.46.4.1016 10.1073/pnas.92.4.1057 10.1038/nm0507-527 10.1016/S0140-6736(89)90038-X 10.1128/JVI.80.5.2495-2505.2006 10.1086/380101 10.1073/pnas.79.6.2031 10.1128/JVI.77.5.2956-2963.2003 10.1097/00126334-200303010-00013 10.1073/pnas.81.8.2534 10.1186/1742-4690-3-15 10.1073/pnas.78.10.6476 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2009 BioMed Central Ltd. Copyright © 2009 Saito et al; licensee BioMed Central Ltd. 2009 Saito et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2009 BioMed Central Ltd. – notice: Copyright © 2009 Saito et al; licensee BioMed Central Ltd. 2009 Saito et al; licensee BioMed Central Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/1742-4690-6-19 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1742-4690 |
EndPage | 19 |
ExternalDocumentID | oai_doaj_org_article_fcbd0fc05d9547dea9c175db8557a539 PMC2653460 oai_biomedcentral_com_1742_4690_6_19 A195140999 19228429 10_1186_1742_4690_6_19 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- 0R~ 123 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 7X8 -A0 3V. ABVAZ ACRMQ ADINQ AFGXO AFNRJ C24 5PM PUEGO |
ID | FETCH-LOGICAL-b579t-e82db7929e5c161ad222bd41421738b5e82fc4201297b61e852a26da44113c353 |
IEDL.DBID | RBZ |
ISSN | 1742-4690 |
IngestDate | Wed Aug 27 01:22:30 EDT 2025 Thu Aug 21 18:45:51 EDT 2025 Wed May 22 07:12:46 EDT 2024 Mon Jul 21 10:04:18 EDT 2025 Tue Jun 17 22:19:20 EDT 2025 Tue Jun 10 21:15:30 EDT 2025 Mon Jul 21 06:03:41 EDT 2025 Tue Jul 01 03:39:28 EDT 2025 Thu Apr 24 23:09:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b579t-e82db7929e5c161ad222bd41421738b5e82fc4201297b61e852a26da44113c353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/1742-4690-6-19 |
PMID | 19228429 |
PQID | 67008911 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_fcbd0fc05d9547dea9c175db8557a539 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2653460 biomedcentral_primary_oai_biomedcentral_com_1742_4690_6_19 proquest_miscellaneous_67008911 gale_infotracmisc_A195140999 gale_infotracacademiconefile_A195140999 pubmed_primary_19228429 crossref_citationtrail_10_1186_1742_4690_6_19 crossref_primary_10_1186_1742_4690_6_19 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-02-19 |
PublicationDateYYYYMMDD | 2009-02-19 |
PublicationDate_xml | – month: 02 year: 2009 text: 2009-02-19 day: 19 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Retrovirology |
PublicationTitleAlternate | Retrovirology |
PublicationYear | 2009 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | F Umehara (1024_CR16) 1998; 57 BJ Poiesz (1024_CR1) 1980; 77 BM Birmann (1024_CR55) 2008; 1:124 A Hasegawa (1024_CR46) 2003; 77 Y Shimizu (1024_CR47) 2008 M Yoshida (1024_CR13) 2001; 19 L Gao (1024_CR26) 2005; 106 JE Green (1024_CR22) 1989; 341 S Kamihira (1024_CR45) 2005; 27 J Arnold (1024_CR34) 2006; 107 M Nomoto (1024_CR40) 1991; 41 F Umehara (1024_CR14) 1994; 53 S Izumo (1024_CR41) 1996; 46 MH Cavanagh (1024_CR39) 2006; 3 Y Yamano (1024_CR17) 2002; 99 AH Sabouri (1024_CR53) 2005; 86 Y Satou (1024_CR32) 2006; 103 K Arisawa (1024_CR7) 2000; 85 AP Hall (1024_CR25) 1998; 186 M Sugimoto (1024_CR9) 1987; 2 NH Ruddle (1024_CR24) 1993; 197 I Higuchi (1024_CR11) 1993; 16 M Osame (1024_CR35) 1990 T Matsuzaki (1024_CR43) 2005; 15:237 CR Bangham (1024_CR12) 2005; 24 M Nagai (1024_CR36) 1998; 4 K Murata (1024_CR38) 2006; 80 M Nerenberg (1024_CR21) 1987; 237 M Matsuoka (1024_CR19) 2005; 2 SH Hinrichs (1024_CR20) 1987; 237 M Yoshida (1024_CR2) 1982; 79 Y Furuta (1024_CR27) 1989; 63 WJ Grossman (1024_CR28) 1995; 92 M Yoshida (1024_CR4) 1984; 81 Y Iwakura (1024_CR23) 1991; 253 JF Kurtzke (1024_CR44) 1983; 33 T Ohsugi (1024_CR30) 2007; 13 G Gaudray (1024_CR31) 2002; 76 KJ Jeffery (1024_CR52) 2000; 165 Y Hinuma (1024_CR3) 1981; 78 M Saito (1024_CR42) 2004; 189 F Umehara (1024_CR15) 1996; 91 H Hasegawa (1024_CR29) 2006; 12 K Nishioka (1024_CR10) 1989; 1 M Mochizuki (1024_CR8) 1992; 83 T Usui (1024_CR37) 2008; 5 A Gessain (1024_CR5) 1985; 2 D Fuchs (1024_CR49) 1988; 9 Y Furukawa (1024_CR18) 1995; 85 Y Furukawa (1024_CR50) 2003; 32 J Basbous (1024_CR33) 2003; 278 Y Furukawa (1024_CR54) 2000; 182 KJ Jeffery (1024_CR51) 1999; 96 M Osame (1024_CR6) 1986; 1 M Nakagawa (1024_CR56) 1996; 2 I Lemasson (1024_CR48) 2007; 81 8212554 - Virology. 1993 Nov;197(1):196-204 16155610 - Oncogene. 2005 Sep 5;24(39):6035-46 15854229 - Retrovirology. 2005;2:27 19154412 - Cancer Sci. 2009 Mar;100(3):481-9 2888190 - Science. 1987 Sep 11;237(4820):1324-9 17479090 - Nat Med. 2007 May;13(5):527-8 16407133 - Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5 11756157 - Blood. 2002 Jan 1;99(1):88-94 12626894 - J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34 10065900 - J Neurovirol. 1998 Dec;4(6):586-93 16550188 - Nat Med. 2006 Apr;12(4):466-72 16512901 - Retrovirology. 2006;3:15 8515755 - Muscle Nerve. 1993 May;16(5):472-6 9737547 - J Neuropathol Exp Neurol. 1998 Sep;57(9):839-49 12584320 - J Virol. 2003 Mar;77(5):2956-63 8780082 - Neurology. 1996 Apr;46(4):1016-21 2888191 - Science. 1987 Sep 11;237(4820):1340-3 16424388 - Blood. 2006 May 15;107(10):3976-82 2890850 - Lancet. 1987 Nov 21;2(8569):1220 12438606 - J Virol. 2002 Dec;76(24):12813-22 11010842 - J Infect Dis. 2000 Nov;182(5):1343-9 1582883 - Jpn J Cancer Res. 1992 Mar;83(3):236-9 8912211 - J Neurovirol. 1996 Oct;2(5):345-55 15722539 - J Gen Virol. 2005 Mar;86(Pt 3):773-81 12937177 - J Biol Chem. 2003 Oct 31;278(44):43620-7 6326131 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2534-7 16118323 - Blood. 2005 Dec 15;106(13):4294-302 1887217 - Science. 1991 Aug 30;253(5023):1026-8 18989900 - Int J Cancer. 2009 Feb 1;124(3):614-21 11120862 - J Immunol. 2000 Dec 15;165(12):7278-84 16474156 - J Virol. 2006 Mar;80(5):2495-505 11244044 - Annu Rev Immunol. 2001;19:475-96 3076770 - Immunol Today. 1988 May;9(5):150-5 8301322 - J Neuropathol Exp Neurol. 1994 Jan;53(1):72-7 8928610 - Acta Neuropathol. 1996;91(4):343-50 6979048 - Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5 7862633 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61 17151132 - J Virol. 2007 Feb;81(4):1543-53 2563817 - Lancet. 1989 Feb 25;1(8635):441 15961107 - J Neurol Sci. 2005 Oct 15;237(1-2):75-81 10652420 - Int J Cancer. 2000 Feb 1;85(3):319-24 2863442 - Lancet. 1985 Aug 24;2(8452):407-10 2006023 - Neurology. 1991 Mar;41(3):457 9924438 - J Pathol. 1998 Oct;186(2):209-14 7703492 - Blood. 1995 Apr 1;85(7):1865-70 10097126 - Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53 18426605 - Retrovirology. 2008;5:34 6261256 - Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 6685237 - Neurology. 1983 Nov;33(11):1444-52 16048490 - Clin Lab Haematol. 2005 Aug;27(4):235-41 2871307 - Lancet. 1986 May 3;1(8488):1031-2 7031654 - Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80 2724422 - J Virol. 1989 Jul;63(7):3185-9 14702150 - J Infect Dis. 2004 Jan 1;189(1):29-40 2788824 - Nature. 1989 Sep 7;341(6237):72-4 |
References_xml | – volume: 2 start-page: 407 year: 1985 ident: 1024_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(85)92734-5 – volume: 278 start-page: 43620 year: 2003 ident: 1024_CR33 publication-title: J Biol Chem doi: 10.1074/jbc.M307275200 – volume: 1:124 start-page: 614 issue: 3 year: 2008 ident: 1024_CR55 publication-title: Int J Cancer doi: 10.1002/ijc.24012 – volume: 86 start-page: 773 year: 2005 ident: 1024_CR53 publication-title: J Gen Virol doi: 10.1099/vir.0.80509-0 – volume: 81 start-page: 1543 year: 2007 ident: 1024_CR48 publication-title: J Virol doi: 10.1128/JVI.00480-06 – volume-title: Cancer Sci year: 2008 ident: 1024_CR47 – volume: 9 start-page: 150 year: 1988 ident: 1024_CR49 publication-title: Immunol Today doi: 10.1016/0167-5699(88)91203-0 – volume: 53 start-page: 72 year: 1994 ident: 1024_CR14 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199401000-00009 – volume: 85 start-page: 319 year: 2000 ident: 1024_CR7 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B – volume: 237 start-page: 1324 year: 1987 ident: 1024_CR21 publication-title: Science doi: 10.1126/science.2888190 – volume: 96 start-page: 3848 year: 1999 ident: 1024_CR51 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.7.3848 – volume: 107 start-page: 3976 year: 2006 ident: 1024_CR34 publication-title: Blood doi: 10.1182/blood-2005-11-4551 – volume: 103 start-page: 720 year: 2006 ident: 1024_CR32 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0507631103 – volume: 12 start-page: 466 year: 2006 ident: 1024_CR29 publication-title: Nat Med doi: 10.1038/nm1389 – volume: 77 start-page: 7415 year: 1980 ident: 1024_CR1 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.77.12.7415 – volume: 182 start-page: 1343 year: 2000 ident: 1024_CR54 publication-title: J Infect Dis doi: 10.1086/315897 – volume: 27 start-page: 235 year: 2005 ident: 1024_CR45 publication-title: Clin Lab Haematol doi: 10.1111/j.1365-2257.2005.00698.x – volume-title: Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP year: 1990 ident: 1024_CR35 – volume: 2 start-page: 345 year: 1996 ident: 1024_CR56 publication-title: J Neurovirol doi: 10.3109/13550289609146899 – volume: 83 start-page: 236 year: 1992 ident: 1024_CR8 publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1992.tb00092.x – volume: 63 start-page: 3185 year: 1989 ident: 1024_CR27 publication-title: J Virol doi: 10.1128/JVI.63.7.3185-3189.1989 – volume: 19 start-page: 475 year: 2001 ident: 1024_CR13 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.19.1.475 – volume: 91 start-page: 343 year: 1996 ident: 1024_CR15 publication-title: Acta Neuropathol (Berl) doi: 10.1007/s004010050435 – volume: 24 start-page: 6035 year: 2005 ident: 1024_CR12 publication-title: Oncogene doi: 10.1038/sj.onc.1208970 – volume: 237 start-page: 1340 year: 1987 ident: 1024_CR20 publication-title: Science doi: 10.1126/science.2888191 – volume: 85 start-page: 1865 year: 1995 ident: 1024_CR18 publication-title: Blood doi: 10.1182/blood.V85.7.1865.bloodjournal8571865 – volume: 5 start-page: 34 year: 2008 ident: 1024_CR37 publication-title: Retrovirology doi: 10.1186/1742-4690-5-34 – volume: 165 start-page: 7278 year: 2000 ident: 1024_CR52 publication-title: J Immunol doi: 10.4049/jimmunol.165.12.7278 – volume: 16 start-page: 472 year: 1993 ident: 1024_CR11 publication-title: Muscle Nerve doi: 10.1002/mus.880160507 – volume: 33 start-page: 1444 year: 1983 ident: 1024_CR44 publication-title: Neurology doi: 10.1212/WNL.33.11.1444 – volume: 197 start-page: 196 year: 1993 ident: 1024_CR24 publication-title: Virology doi: 10.1006/viro.1993.1580 – volume: 41 start-page: 457 year: 1991 ident: 1024_CR40 publication-title: Neurology doi: 10.1212/WNL.41.3.457 – volume: 57 start-page: 839 year: 1998 ident: 1024_CR16 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199809000-00005 – volume: 2 start-page: 1220 year: 1987 ident: 1024_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(87)91362-6 – volume: 99 start-page: 88 year: 2002 ident: 1024_CR17 publication-title: Blood doi: 10.1182/blood.V99.1.88 – volume: 341 start-page: 72 year: 1989 ident: 1024_CR22 publication-title: Nature doi: 10.1038/341072a0 – volume: 15:237 start-page: 1 issue: 1–2 year: 2005 ident: 1024_CR43 publication-title: J Neurol Sci – volume: 186 start-page: 209 year: 1998 ident: 1024_CR25 publication-title: J Pathol doi: 10.1002/(SICI)1096-9896(1998100)186:2<209::AID-PATH162>3.0.CO;2-I – volume: 76 start-page: 12813 year: 2002 ident: 1024_CR31 publication-title: J Virol doi: 10.1128/JVI.76.24.12813-12822.2002 – volume: 1 start-page: 1031 year: 1986 ident: 1024_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(86)91298-5 – volume: 2 start-page: 27 year: 2005 ident: 1024_CR19 publication-title: Retrovirology doi: 10.1186/1742-4690-2-27 – volume: 106 start-page: 4294 year: 2005 ident: 1024_CR26 publication-title: Blood doi: 10.1182/blood-2005-04-1730 – volume: 4 start-page: 586 year: 1998 ident: 1024_CR36 publication-title: J Neurovirol doi: 10.3109/13550289809114225 – volume: 253 start-page: 1026 year: 1991 ident: 1024_CR23 publication-title: Science doi: 10.1126/science.1887217 – volume: 46 start-page: 1016 year: 1996 ident: 1024_CR41 publication-title: Neurology doi: 10.1212/WNL.46.4.1016 – volume: 92 start-page: 1057 year: 1995 ident: 1024_CR28 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.92.4.1057 – volume: 13 start-page: 527 year: 2007 ident: 1024_CR30 publication-title: Nat Med doi: 10.1038/nm0507-527 – volume: 1 start-page: 441 year: 1989 ident: 1024_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(89)90038-X – volume: 80 start-page: 2495 year: 2006 ident: 1024_CR38 publication-title: J Virol doi: 10.1128/JVI.80.5.2495-2505.2006 – volume: 189 start-page: 29 year: 2004 ident: 1024_CR42 publication-title: J Infect Dis doi: 10.1086/380101 – volume: 79 start-page: 2031 year: 1982 ident: 1024_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.79.6.2031 – volume: 77 start-page: 2956 year: 2003 ident: 1024_CR46 publication-title: J Virol doi: 10.1128/JVI.77.5.2956-2963.2003 – volume: 32 start-page: 328 year: 2003 ident: 1024_CR50 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200303010-00013 – volume: 81 start-page: 2534 year: 1984 ident: 1024_CR4 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.81.8.2534 – volume: 3 start-page: 15 year: 2006 ident: 1024_CR39 publication-title: Retrovirology doi: 10.1186/1742-4690-3-15 – volume: 78 start-page: 6476 year: 1981 ident: 1024_CR3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.78.10.6476 – reference: 2871307 - Lancet. 1986 May 3;1(8488):1031-2 – reference: 2006023 - Neurology. 1991 Mar;41(3):457 – reference: 16118323 - Blood. 2005 Dec 15;106(13):4294-302 – reference: 12937177 - J Biol Chem. 2003 Oct 31;278(44):43620-7 – reference: 8912211 - J Neurovirol. 1996 Oct;2(5):345-55 – reference: 6979048 - Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5 – reference: 10652420 - Int J Cancer. 2000 Feb 1;85(3):319-24 – reference: 8301322 - J Neuropathol Exp Neurol. 1994 Jan;53(1):72-7 – reference: 17479090 - Nat Med. 2007 May;13(5):527-8 – reference: 6326131 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2534-7 – reference: 2888191 - Science. 1987 Sep 11;237(4820):1340-3 – reference: 12626894 - J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34 – reference: 16155610 - Oncogene. 2005 Sep 5;24(39):6035-46 – reference: 17151132 - J Virol. 2007 Feb;81(4):1543-53 – reference: 15854229 - Retrovirology. 2005;2:27 – reference: 2863442 - Lancet. 1985 Aug 24;2(8452):407-10 – reference: 6261256 - Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 – reference: 15722539 - J Gen Virol. 2005 Mar;86(Pt 3):773-81 – reference: 16550188 - Nat Med. 2006 Apr;12(4):466-72 – reference: 11120862 - J Immunol. 2000 Dec 15;165(12):7278-84 – reference: 18426605 - Retrovirology. 2008;5:34 – reference: 3076770 - Immunol Today. 1988 May;9(5):150-5 – reference: 8212554 - Virology. 1993 Nov;197(1):196-204 – reference: 14702150 - J Infect Dis. 2004 Jan 1;189(1):29-40 – reference: 10097126 - Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53 – reference: 2563817 - Lancet. 1989 Feb 25;1(8635):441 – reference: 19154412 - Cancer Sci. 2009 Mar;100(3):481-9 – reference: 7703492 - Blood. 1995 Apr 1;85(7):1865-70 – reference: 1582883 - Jpn J Cancer Res. 1992 Mar;83(3):236-9 – reference: 1887217 - Science. 1991 Aug 30;253(5023):1026-8 – reference: 16407133 - Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5 – reference: 2888190 - Science. 1987 Sep 11;237(4820):1324-9 – reference: 7862633 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61 – reference: 18989900 - Int J Cancer. 2009 Feb 1;124(3):614-21 – reference: 2724422 - J Virol. 1989 Jul;63(7):3185-9 – reference: 16474156 - J Virol. 2006 Mar;80(5):2495-505 – reference: 16424388 - Blood. 2006 May 15;107(10):3976-82 – reference: 6685237 - Neurology. 1983 Nov;33(11):1444-52 – reference: 2788824 - Nature. 1989 Sep 7;341(6237):72-4 – reference: 9737547 - J Neuropathol Exp Neurol. 1998 Sep;57(9):839-49 – reference: 7031654 - Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80 – reference: 8515755 - Muscle Nerve. 1993 May;16(5):472-6 – reference: 12584320 - J Virol. 2003 Mar;77(5):2956-63 – reference: 9924438 - J Pathol. 1998 Oct;186(2):209-14 – reference: 10065900 - J Neurovirol. 1998 Dec;4(6):586-93 – reference: 2890850 - Lancet. 1987 Nov 21;2(8569):1220 – reference: 11244044 - Annu Rev Immunol. 2001;19:475-96 – reference: 15961107 - J Neurol Sci. 2005 Oct 15;237(1-2):75-81 – reference: 16048490 - Clin Lab Haematol. 2005 Aug;27(4):235-41 – reference: 8780082 - Neurology. 1996 Apr;46(4):1016-21 – reference: 16512901 - Retrovirology. 2006;3:15 – reference: 8928610 - Acta Neuropathol. 1996;91(4):343-50 – reference: 11010842 - J Infect Dis. 2000 Nov;182(5):1343-9 – reference: 12438606 - J Virol. 2002 Dec;76(24):12813-22 – reference: 11756157 - Blood. 2002 Jan 1;99(1):88-94 |
SSID | ssj0031808 |
Score | 2.2849119 |
Snippet | Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to... BACKGROUND: Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was... Abstract Background Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered... |
SourceID | doaj pubmedcentral biomedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 19 |
SubjectTerms | Aged Basic-Leucine Zipper Transcription Factors - genetics Basic-Leucine Zipper Transcription Factors - immunology Case-Control Studies Cell Line, Tumor Cells, Cultured Female Gene expression Gene Products, tax - genetics Gene Products, tax - immunology Genetic aspects HTLV-I infections Human T-lymphotropic virus 1 - genetics Human T-lymphotropic virus 1 - immunology Humans Interferon-alpha - therapeutic use Leucine Leukemia-Lymphoma, Adult T-Cell - drug therapy Leukemia-Lymphoma, Adult T-Cell - immunology Leukemia-Lymphoma, Adult T-Cell - virology Leukocytes, Mononuclear - immunology Leukocytes, Mononuclear - virology Male Measurement Messenger RNA Middle Aged Neopterin - cerebrospinal fluid Paraparesis, Tropical Spastic - drug therapy Paraparesis, Tropical Spastic - immunology Paraparesis, Tropical Spastic - virology Retroviridae Proteins Severity of Illness Index Spinal Cord Diseases - drug therapy Spinal Cord Diseases - immunology Spinal Cord Diseases - virology Viral Load Viral Proteins - genetics Viral Proteins - immunology Viremia |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yIPgi3h1d9TwIKlimt7SNb7PiUsUVwVlZfAm5lR2YaZed2cX5b_44z0nbdcIivvjYJm1uX875kpycw9jLJE-TvHE6MkgOKISZiYRBYchTJYyIlVXeffHRl6I-zj-d8JOdUF9kE9a7B-47btoYbePGxNwKnpfWKfoVt7rivFQ881f3UOeNi6leBiNQfSw6pNtYAVwADu4ak6qYXr2Lioj86wT33JeBevJe_K_L6h1lFRpS7mimwzvs9kApYdY35S674dp77GYfZHJ7n_362MLl4rID93Mwem2hawCJH9QHPwAB5Oi5nn_-HiVgKFrHkggo0BYt-C0HLBSWnbJvAfGIEFr5o3lYkWnP-RpUa2E46AFUtI7i4WHO8ZdqQICzsNqShRKSzi0ZKZ8RQABFGvmKBnJCTubw68UaXtezo-n829c3D9jx4Yf5-zoaYjZEmpdiE7kqtbpEzuW4QTKpLPIPbXOCRJlVmmN6Y_KUtr9KXSSuQlCkhVXIypLMZDx7yPbarnWPGcQ8NtwhwxTW5VpxwQ1PGt5UonSlisWEvQuGTp71_jkkecwOU3DyShp3SeMuC5ngx9E4ztIM3tApKMdS-lVRVVzL_-oq_1jO33IeEGyC2vgXiGo5oFr-C9VYHIFOkpTBahk1XJbAniF_XXKWIDPOid1P2H6QE6WDCZJfjLCVlEQmda3rLtaS7mdVqOom7FEP4j_tEimSlhS_LQN4B00KU9rFqXdNnhY8y4v4yf_og6fsVn90l-I83Wd7m_ML9wwZ4EY_95P9N1fmWZE priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELbQJiS-IMZrYcB9QAIkwvLmJEZCqENMBVGERIsmvliO7UClNBlNN63_jR_HnZN2CwWJj43PdWI_53tsn-8YexLEYRAXNvc0kgNKYaY9oXEy5KESWvjKKBe-ePwpGU3jD8f8-ML_qevA5q9LO8onNV2UL89_rt6gwr92Cp8lB0iqsRlc5nmJRxFAd9EqpZTNYBxvThQQui473Ua2C-C4Xf-Pm-9lz2C5uP7bs_cl89V3rbxkq45usOsdyYRhi4o9dsVWN9nVNu3k6hb79b6Cs9lZDfa8c4OtoC4AqSCMDr8BQsrS79Hk41cvAE35O0qipECbtuA2IbBRKGtlXgD2GYJq7g7rYU7OPosGVGWgO_oBNL2WMuSh5PovVYcJa2C-Ip8lpKErcls-IcgATnIUPRooLDk5yDezBp6NhuODyZfPz2-z6dG7yduR12Vx8HKeiqVns9DkKbIwyzXSS2WQkeQmJpCkUZZzLC90HNKGWJongc0QJmFiFPK0INIRj-6wnaqu7D0GPvc1t8g5hbFxrrjgmgcFLzKR2lT5YsBe9YZOnrQROyTF0O6XoDpLGndJ4y4TGWBlbz3OUnfx0SlNRyndOilLtuSfbuTX7fxL8pBg03sb96BefJfdBCELnRu_0D43gsepsYpUhps84zxVPKLmCHSSNAFfS6vu-gT2DEXwksMAuXJMfH_A9nuSOF_oXvHjNWwlFZGTXWXr00bSja0Mjd-A3W1BfPFdIkQaE2LdtAfv3if1S6rZDxesPEx4FCf-_f_urQfsWntiF6Iy7rOd5eLUPkTit8wfOY3-DZbjVRE priority: 102 providerName: Scholars Portal |
Title | In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19228429 https://www.proquest.com/docview/67008911 http://dx.doi.org/10.1186/1742-4690-6-19 https://pubmed.ncbi.nlm.nih.gov/PMC2653460 https://doaj.org/article/fcbd0fc05d9547dea9c175db8557a539 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgExIviG8Ko9wDEiARLR92nPDWok0B0WmCDlV7sRzbEZXaZFq7if5v_HHc5WNbVvHES6XG5zjJ_Xz-2T7fMfY24GHAC5d7BskBpTAzXmrQGIpQpyb1tdV1-OLJUZyd8K8zMbte77i1gx8k8T5SZrwJTuK82KP4nrshxys0Lx-fdjYXgVnnnruSbcMzbte_da590RuO6qj927b5xuDUd5y8MRIdPmQPWgoJo0bnj9gdVz5m95qkkpsn7M-XEi7nlxW4362TawlVAUj0IBufAgLG0f9s-u2nF4Ch7BwLIpxAS7JQLzFgo7CotP0IiD-EzLLeioclufKcr0CXFtqNHcCB1VH-O5TsbqlbjTsLyw15JCHJ3JBT8hkBAtCEUWxooKDj5P6-mq_gfTaa7E9_HH94yk4OD6afM6_N0eDlQqZrzyWhzSVyLCcMkkdtkW_klhMEZJTkAssLw0Na7pJ5HLgEQRDGViMLCyITiegZ2ymr0r1g4AvfCIeMMrWO51qkwoigEEWSSie1nw7Yp57q1FkTj0NRhOx-CXZWRXpXpHcVqwAre52elWmjn1MSjoWqZ0FJvCX_7kq-a-dfkmOCTe9p6gsIYtV2f1WY3PqF8YVNBZfWaeoQwuaJEFKLiJoj0CmyKvhYRreHI_DLUHwuNQqQCXNi8wO215NEa2B6xW862CoqIhe60lUXK0XnsRIc2gbseQPi6_dKQyQpIdaVPXj3XqlfUs5_1aHIw1hEPPZf_o9qXrH7zRZdiP1zj-2szy_ca2R663zI7sqZHLLd8cHR8fdhvV6CvxOeDOvu_xeKGFTY |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLamIQQviPsKg50HJEAiLDfnwluLGBm0ExIdmvZiObYDldpkSruJ_jd-HOc4yWioeOIx9XEc15-PP9vnwtgLL_S9sDC5o5AcUAoz5aQKlSH3ZapSV2ppwxdPTqLsNPx0xs922MfOF6Y2K9pK1_ZM-e2mC_rc6u3OXKyZ7Ul0iIwa28A9nhM5FP7zRsx5bB25RuedSkbc2tR017Jt9Mbt-n-5vc97q5UN6r-tujfWrr5d5cZCdXSX3WkZJgybLtxjO6a8z242OSfXD9iv4xKuZlcVmJ-tDWwJVQHIAyEbnQPiydBzNh1_czxQlLxjTnwU6MQW7AkENgrzSuo3gPBERC3sTT0syNKnXoIsNbT3PoDrrqH0eCjZvVK2gDAaFmsyWEIOuiab5QvCC6CGo9DRQDHJyTp-OVvCq2w4OZx-_fL6ITs9-jB9nzltCgcn53G6ckzi6zxGCma4Qm4pNdKRXIeEkDhIco7lhQp9Og2L88gzCWLEj7REkuYFKuDBI7ZbVqXZY-ByV3GDhDPVJswlT7niXsGLJI1NLN10wN71hk5cNOE6BAXQ7pcgkASNu6BxF5HwsLLTjbNQbXB0ytExF3aTlERb8i-v5bt2_iU5Itj0vsb-UNXfRYtmUahcu4VyuU55GGsjab5wnSeIZckDao5AJ0jp4Gcp2fpO4D9D4bvE0EOiHBLZH7D9niQqC9UrPuhgK6iILOxKU10uBblrJbjyDdjjBsR_-pX6yGF8rBv34N3rUr-knP2wkcr9iAdh5D75n6E5YLey6WQsxscnn5-y281tno9zdZ_trupL8wxJ4Sp_bif8b0doYHE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELaqIhAXxJtAoXNAAiSW7Mv74JYA0RbaqoIUVb1YXtsLEclulKQV-W_8OGa8uyVLxIlbEo_jbPx5_Nkef8PYcy_0vbAwuaOQHFAKM-WkCp0h92WqUldqaeWLj46j7DT8eMbPdljW3oVZmBUtpRd2T_nN5hX0qfXb-EL96M91UQ_3JOojpcZGcJHnRA7pf16LOY8pl8Hn4XnrkxG4NjfdlW0j37hd_69779POdGVV_bd998bk1Q2s3JipRrfZrYZiwqDGxB22Y8q77HqddHJ9j_06KOFyclmB-dkEwZZQFYBEELLhOSCgDL3PxodfHQ8UZe-YEiEF2rIFuwWBjcK0kvo1ID4RUjN7VA8zCvVZLEGWGpqDH8CJ11B-PLRsv1I2iDAaZmuKWEISuqag5TkBBtDFkXY0kCg5hccvJ0t4mQ2O-uMvJ6_us9PRh_G7zGlyODg5j9OVYxJf5zFyMMMVkkupkY_kOiSIxEGScywvVOjTdlicR55JECR-pCWyNC9QAQ8esN2yKs0jBi53FTfIOFNtwlzylCvuFbxI0tjE0k177G2n68S81usQpKDdLUEkCep3Qf0uIuFhZaftZ6EadXRK0jEVdpWURFv2L67s23b-ZTkk2HR-jf2gWnwTjXsQhcq1WyiX65SHsTaSBgzXeYJYljyg5gh0grwODQHZXJ7Af4b0u8TAQ6YcEtvvsb2OJXoL1Sneb2ErqIhC7EpTXSwF3ddKcOrrsYc1iP88V-ojifGxbtyBd-eRuiXl5LuVKvcjHoSR-_h_umaf3Th5PxKHB8efnrCb9Wmej0N1j-2uFhfmKZLCVf7MjvffoCxgPA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vivo+expression+of+the+HBZ+gene+of+HTLV-1+correlates+with+proviral+load%2C+inflammatory+markers+and+disease+severity+in+HTLV-1+associated+myelopathy%2Ftropical+spastic+paraparesis+%28HAM%2FTSP%29&rft.jtitle=Retrovirology&rft.au=Saito%2C+Mineki&rft.au=Matsuzaki%2C+Toshio&rft.au=Satou%2C+Yorifumi&rft.au=Yasunaga%2C+Jun-ichirou&rft.date=2009-02-19&rft.issn=1742-4690&rft.eissn=1742-4690&rft.volume=6&rft.issue=1&rft_id=info:doi/10.1186%2F1742-4690-6-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_1742_4690_6_19 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4690&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4690&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4690&client=summon |